Respiratory Medicine
Volume 103, Issue 11 , Pages 1623-1632 , November 2009

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice

  • Pascal Demoly

      Affiliations

    • University Hospital of Montpellier and INSERM U657, Hôpital Arnaud de Villeneuve, Montpellier, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 467336127; fax: +33 467042708.
    • ,
  • Renaud Louis

      Affiliations

    • Department of Pneumology CHU Liege, Giga Research Group, University of Liege, Belgium
    • ,
  • Ulrik Søes-Petersen

      Affiliations

    • Medicinsk Afdeling, Lungemedicinsk Sektion, Roskilde Sygehus, Roskilde, Denmark
    • ,
  • Ian Naya

      Affiliations

    • AstraZeneca R&D, Lund, Sweden
    • ,
  • Åsa Carlsheimer

      Affiliations

    • AstraZeneca R&D, Lund, Sweden
    • ,
  • Heinrich Worth

      Affiliations

    • Medizinische Klinik I, Klinikum Fürth, Akademisches Lehrkrankenhaus der Universität Erlangen-Nürnberg, Fürth, Germany
    • ,
  • Joao Almeida

      Affiliations

    • Hospital de S. João, Porto, Portugal
    • ,
  • Malcolm R. Sears

      Affiliations

    • Firestone Institute for Respiratory Health, St. Joseph's Healthcare and McMaster University, Hamilton, Ontario, Canada

Received 20 February 2009 ,Accepted 29 July 2009.

References 

  1. Global Initiative for Asthma . Global strategy for asthma management and prevention – updated 2007. Available at: www.ginasthma.com[accessed January 2009]
  2. British Thoracic Society and Scottish Intercollegiate Guidelines Network . British guideline on the management of asthma: a national clinical guideline. Available at: http://www.brit-thoracic.org.uk2008;[accessed January 2009]
  3. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30:452–456
  4. Barnes PJ. Scientific rationale for using a single inhaler for asthma control. Eur Respir J. 2007;29:587–595
  5. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368:744–753
  6. Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007;61:725–736
  7. Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. High-dose salmeterol/fluticasone. Respir Med. 2007;101:2437–2446
  8. Sears MR, Boulet LP, Laviolette M, et al. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. Eur Respir J. 2008;31:982–989
  9. Louis R, Joos G, Michiels A, Vandenhoven G, De Schepper I, Duquenne V. Budesonide/formoterol maintenance and reliever therapy compared to conventional best practice in the treatment of persistent asthma. Eur Respir J. 2007;30:616s
  10. Soes-Petersen U, Kava T, Dahl R, Lei Y, Dam N. Budesonide/formoterol maintenance and reliever therapy compared with conventional best standard treatment. Eur Respir J. 2008;32:(Suppl 52):P3508
  11. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the asthma control questionnaire. Respir Med. 2006;100:616–621
  12. Juniper EF, O'Byrne PM, Roberts JN. Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use?. Respir Med. 2001;95:319–323
  13. American Thoracic Society . Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225–244
  14. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902–907
  15. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med. 2004;170:836–844
  16. Vogelmeier C, D'Urzo A, Pauwels R, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?. Eur Respir J. 2005;26:819–828
  17. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med. 1982;1:121–129
  18. Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest. 2006;129:246–256
  19. Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20:1403–1418
  20. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171:129–136
  21. Efron B, Tibshirani RJ. Introduction to the bootstrap. New York: Chapman & Hall; 1993;
  22. Pedersen SE, Bateman ED, Bousquet J, Busse WW, Yoxall S, Clark TJ. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the gaining optimal asthma control study. J Allergy Clin Immunol. 2007;120:1036–1042
  23. Pauwels RA, Sears MR, Campbell M, et al. Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J. 2003;22:787–794
  24. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008;31:320–325
  25. Clinicaltrials.gov . Local phase 4 pan-European SMART study. Available at: http://clinicaltrials.gov/ct2/show/NCT00463866?term=eurosmart&rank=12008;[accessed January 2009]
  26. Burney P, Potts J, Ait-Khaled N, et al. A multinational study of treatment failures in asthma management. Int J Tuberc Lung Dis. 2008;12:13–18
  27. Teach SJ, Crain EF, Quint DM, Hylan ML, Joseph JG. Improved asthma outcomes in a high-morbidity pediatric population: results of an emergency department-based randomized clinical trial. Arch Pediatr Adolesc Med. 2006;160:535–541
  28. Hamid S, Kumaradevan J, Cochrane GM. Single centre open study to compare patient recording of PRN salbutamol use on a daily diary card with actual use as recorded by the MDI compliance monitor. Respir Med. 1998;92:1188–1190

PII: S0954-6111(09)00255-8

doi: 10.1016/j.rmed.2009.07.018

Respiratory Medicine
Volume 103, Issue 11 , Pages 1623-1632 , November 2009

Article Tools

* Image Usage & Resolution